Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CTX001
CTX001
A big year for sickle cell
EP Vantage
Tue, 03/1/22 - 10:12 am
sickle cell disease
Agios
mitapivat
CRISPR Therapeutics
CTX001
clinical trials
Vertex puts a blockbuster valuation on its CRISPR deal
EP Vantage
Tue, 04/20/21 - 11:05 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
CTX001
M&A
CRISPR and Vertex Release Additional Data for Blood Disease Treatment
Motley Fool
Wed, 11/4/20 - 10:50 pm
CRISPR Therapeutics
CRISPR
Vertex Pharmaceuticals
CTX001
beta thalassemia
sickle cell disease
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
Fierce Biotech
Mon, 06/15/20 - 10:35 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
gene editing
sickle cell disease
beta thalassemia
Derailed by the pandemic, FDA offers CRISPR, Vertex drug program VIP status for its comeback play
Endpoints
Mon, 05/11/20 - 10:16 am
CRISPR Therapeutics
Vertex Pharmaceuticals
CTX001
pandemic
COVID-19
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
Endpoints
Mon, 10/28/19 - 10:54 am
Vertex Pharmaceuticals
CRISPR
gene editing
CTX001
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test
Xconomy
Wed, 10/10/18 - 10:49 pm
CRISPR Therapeutics
Vertex Pharmaceuticals
sickle cell disease
FDA
CTX001
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Mon, 09/3/18 - 12:20 pm
Amarin
CRISPR Therapeutics
Geron
Vascepa
Vertex Pharmaceuticals
CTX001
JNJ
imetelstat
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study
Xconomy
Wed, 05/30/18 - 08:58 pm
sickle cell disease
FDA
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
stem cells